Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju Liu

Showing results (1281-1290 of 1,293) with videos related to

Pageof 130
Sort By:
The Lancet. Gastroenterology & Hepatology|January 14, 2020
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled studyYing-Xuan Chen, Qin-Yan Gao, Tian-Hui Zou, et al.
Chest|March 11, 2026
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trialLi-Xiu He, Ling Yang, Zu-Ke Xiao, et al.
Plos Medicine|October 19, 2019
Redesigning care for older people to preserve physical and mental capacity: WHO guidelines on community-level interventions in integrated careJotheeswaran Amuthavalli Thiyagarajan, Islene Araujo de Carvalho, Juan Pablo Peña-Rosas, et al.
Cellular & Molecular Immunology|December 31, 2025
MDA5 regulates BCR signaling and B-cell function via NF-κB-mediated DNM1Li Luo, Yi Wang, Guofeng Fang, et al.
JAMA Network Open|May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical TrialJian Zhu, Cheng Zhao, Cundong Mi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2013
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeuticsMartin A Maier, Muthusamy Jayaraman, Shigeo Matsuda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 22, 2021
The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of <i>N</i>-Acetylgalactosamine-Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to HumanRobin McDougall, Diane Ramsden, Sagar Agarwal, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyShangzhu Zhang, Dong Xu, Shengyun Liu, et al.
Thorax|June 17, 2022
Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre studyChao-Chien Wu, Chin-Chou Wang, Wen-Yu Chung, et al.
Pageof 130

Showing results (1281-1290 of 1,293) with videos related to

Sort By:
Pageof 130
The Lancet. Gastroenterology & Hepatology|January 14, 2020
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled studyYing-Xuan Chen, Qin-Yan Gao, Tian-Hui Zou, et al.
Chest|March 11, 2026
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trialLi-Xiu He, Ling Yang, Zu-Ke Xiao, et al.
Plos Medicine|October 19, 2019
Redesigning care for older people to preserve physical and mental capacity: WHO guidelines on community-level interventions in integrated careJotheeswaran Amuthavalli Thiyagarajan, Islene Araujo de Carvalho, Juan Pablo Peña-Rosas, et al.
Cellular & Molecular Immunology|December 31, 2025
MDA5 regulates BCR signaling and B-cell function via NF-κB-mediated DNM1Li Luo, Yi Wang, Guofeng Fang, et al.
JAMA Network Open|May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical TrialJian Zhu, Cheng Zhao, Cundong Mi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2013
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeuticsMartin A Maier, Muthusamy Jayaraman, Shigeo Matsuda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 22, 2021
The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of <i>N</i>-Acetylgalactosamine-Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to HumanRobin McDougall, Diane Ramsden, Sagar Agarwal, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyShangzhu Zhang, Dong Xu, Shengyun Liu, et al.
Thorax|June 17, 2022
Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre studyChao-Chien Wu, Chin-Chou Wang, Wen-Yu Chung, et al.
Pageof 130